Results 21 to 30 of about 4,865 (116)

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Prospective study of pharmacokinetics of isavuconazole in critically ill patients undergoing continuous hemodialysis with and without acute-on-chronic liver failure. [PDF]

Ann Intensive Care
Behrens E, König C, Jarczak D, Martens-Lobenhoffer J, Bode-Böger SM, Kluge S, Wicha SG, Fuhrmann V, Grensemann J.   +8 more
europepmc   +1 more source

Breakthrough Tracheobronchial Aspergillosis Caused by <i>Aspergillus calidoustus</i> and <i>Aspergillus niger</i> in a Lung Transplant Recipient Despite Combined Antifungal Prophylaxis. [PDF]

Case Rep Pulmonol
Calvache Benavides CE, Rodríguez Cárdenas MD, Sánchez Salazar SS, Treviño Rangel RJ, Camacho Ortiz A.   +4 more
europepmc   +1 more source

Disseminated <i>Verruconis gallopava</i> in a kidney transplant recipient on belatacept, who failed isavuconazole and improved on dual amphotericin B and posaconazole therapy. [PDF]

Med Mycol Case Rep
Cappiello M, Corpuz Bonus MC, Chang S, Arcobello J.   +3 more
europepmc   +1 more source

Case Report: Pediatric isavuconazole supratherapeutic exposure: a case of long-term use, CYP3A5 poor metabolizer genotype and concomitant CYP3A4 medications. [PDF]

Front Pharmacol
Liu M, Li L, Zhou C, Luo C, Wang X, Wu J.   +5 more
europepmc   +1 more source

Liver Necrosis in a Patient Receiving Isavuconazole: Making the Case for Therapeutic Drug Monitoring. [PDF]

Open Forum Infect Dis
Miceli MH, Eschenauer GA, Kauffman CA.
europepmc   +1 more source

Comparative risk of arrhythmias associated with systemic antifungal agents: a disproportionality analysis of the FAERS database. [PDF]

Front Pharmacol
Yang X, Li H, Liu K, Kong L.
europepmc   +1 more source

Can voriconazole gradient diffusion testing results be extrapolated to isavuconazole and posaconazole in <i>Aspergillus</i> spp.? Comparative analysis with CLSI broth microdilution and <i>cyp51A</i> gene sequencing. [PDF]

Antimicrob Agents Chemother
Vahedi-Shahandashti R, Nickel A-S, Eisele D, Lass-Flörl C, ISHAM Working Group Member of Intrinsic Antifungal Resistance.   +4 more
europepmc   +1 more source

Emerging evidence for anti-PD-1 and IFN-γ as adjunctive immunotherapy in invasive mold infections. [PDF]

mBio
Serris A, Guihot A, Joffre J, Dessajan J, Dahuron L, Bosch A, Dudoignon E, Pierot L, Lelièvre L, Lukaszewicz AC, Monneret G, Lambotte O, Martin-Blondel G, Lanternier F.   +13 more
europepmc   +1 more source

Prevalence of cyp51A variants in a US collection of Aspergillus fumigatus clinical isolates and comparative analysis of their contribution to triazole antifungal resistance. [PDF]

J Antimicrob Chemother
Gómez Londoño LF, Souza ACO, Burt B, Das S, Ge W, Meza-Perez V, Wiederhold NP, Shelat AA, Cuomo CA, Fortwendel JR, Rogers PD.   +10 more
europepmc   +1 more source